x

Join Advarra

Learn more about our company team, careers, and values. Join Advarra’s Talented team to take on engaging work in a dynamic environment.

See Jobs

Judith Carrithers, JD, MPA

Vice President, IRB Review, Advarra

Judith Carrithers has worked in the field of human subject protection for more than 20 years. Prior to joining Advarra, she served as the Assistant Dean for Human Research Protection at Johns Hopkins University School of Medicine. Carrithers co‐leads the Ethics and Regulatory Core for the NIH Health Care Systems Research Collaboratory. She is also a consultant on regulatory issues in the field of human subject protection, has presented at local, national and international meetings.

Judith Carrithers

Latest Posts by Judith

 
Blog

Q&A – The New Normal: Considerations for Restarting Research

Experts answer some of the most popular audience questions from the recent webinar The New Normal: Considerations for Restart Research. Read more:

Read Now
7 min. read
Read more
 
Webinar

The New Normal: Considerations for Restarting Research

June 3, 2020

Throughout the COVID-19 pandemic, we have continually heard what the “new normal” could mean for our work lives, social lives, schools, communities, and our medical system. But what does it ...

Watch Now
Read more
 
Blog

Q&A – Ask Advarra Live: The Real-World Impact of COVID-19 on Research

We have addressed the most popular Q&A topics from our recent webinar on the research impact of COVID-19 in this blog post. Read more:

Read Now
6 min. read
Read more
 
Webinar

Ask Advarra Live: The Real-World Impact of COVID-19 on Research

April 2, 2020

The unprecedented COVID-19 pandemic has quickly changed how we live and work. This extraordinary situation has resulted in a significant impact on IRB-approved protocols and research yet to go through ...

Watch Now
Read more
 
Blog

After the Compliance Date: Revised Common Rule FAQs (Or: Why We Cancelled Our February Webinar)

We have cancelled our webinar “After the Compliance Date: Revised Common Rule FAQs,” which was originally scheduled for February 28.

Read Now
Read more